J.P. Morgan Reiterates Neutral Rating on Kindred Healthcare (KND)

J.P. Morgan is out with a research report this morning, where it reiterates its Neutral rating on Kindred Healthcare Inc. KND; it has an $18.00 price target on the stock. The JPM analysts cited the company’s recent earnings report, which was better than expected; the company reiterates their 2010 EPS guidance, though lowered their outlook for revenues and EBITDAR. The analysts also noted that during the quarter revenues missed estimates for two of the company’s product lines, with LTCHs missing by 3.4%, SNFs missing by 1.0%. Rehab was the one winner, with revenues beating estimates by 0.5%. Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates hospitals, nursing and rehabilitation centers and a contract rehabilitation services business across the United States.